EMACOLEX meeting in Reykjavik - 15.10.2013

Informal meeting, of a group involving lawyers and regulatory experts from competent authorities from the EEA Member States with a mandate of the Heads of Medicines Agencies (HMA) and Switzerland, in Reykjavik 17 -18 October 2013.

Fighting availability problems - 4.9.2013

IMA has informed of and promoted how easy it is to market medicinal and veterinary medicinal products in Iceland, not the least by using multilingual packages.

IMA's Annual Report 2012 - 12.7.2013

IMA's Annual Report 2012 has been published on the website

Rules on reduction of fees collected by IMA - 2.7.2013

Rules concerning reduction of fees collected in accordance with Tariff 635/2011 have been changed.

Updated - Receipt of clinical trial applications (CTA) summer 2013 - 1.7.2013

Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications (CTA) from 1. July to 16. August 2013.

IMA publishes data about drug consumption in Iceland - 29.5.2013

The published data contains information about drug consumption in Iceland from 2008-2012.

Revocation of S - classification postponed. - 10.5.2013

The Icelandic Medicines Agency postpones revocation of S – classification of certain medicinal products.

Labels on Risk Communication Material to Health Care Professionals - 21.3.2013

Labels for risk communication material to healthcare professionals can also be used on cover letters with this material and DHPs letters.

Rules concerning reduction of fees collected in accordance with Tariff No 635/2011 - 18.2.2013

Rules concerning reduction of fees collected in accordance with Tariff No 635/2011 have been changed, i.e. the implementation of certain parts of the rules is postponed until 1 February 2014.

See All